McKesson (MCK) Stock Price
McKesson Price
McKesson (MCK) Stock | ISIN US58155Q1031 | WKN 893953. The current McKesson stock price is 766.64 USD (2026). Revenue is 412.79 B USD. Net income is 4.79 B USD. The P/E ratio is 20.51. Market capitalization is 93.91 B USD. McKesson operates in the Health sector.
McKesson stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of McKesson over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how McKesson stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing McKesson's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | McKesson Price |
|---|
McKesson Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
McKesson Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales McKesson generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue McKesson retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare McKesson's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares McKesson has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against McKesson's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
McKesson stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
McKesson Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
McKesson business model & stock analysis
McKesson SWOT Analysis
Strengths
Mckesson Corp holds a prominent position in the healthcare industry, making it a key player in the market.
The company benefits from a well-established and efficient distribution network, ensuring timely delivery of products and services.
Mckesson Corp offers a wide range of healthcare solutions and services, catering to various needs and requirements.
Weaknesses
A significant portion of Mckesson Corp's revenue is derived from a few key customers, increasing vulnerability to their actions and demands.
As a healthcare company, Mckesson Corp is subject to stringent regulations and compliance requirements, which may pose operational challenges.
The company needs to continually focus on cost management strategies to maintain profitability in the highly competitive market.
Opportunities
The healthcare industry is expected to experience significant growth in the coming years, presenting opportunities for Mckesson Corp to expand its market reach.
Leveraging technology and embracing digital transformation can enhance efficiency, improve patient outcomes, and provide new avenues for revenue generation.
Exploring international markets can help Mckesson Corp tap into new customer bases and diversify its revenue streams.
Threats
The healthcare industry is highly competitive, with numerous players vying for market share, potentially impacting Mckesson Corp's growth prospects.
Fluctuations in government policies and economic conditions can create uncertainty and impact the overall healthcare market and Mckesson Corp's operations.
As a custodian of sensitive patient data, Mckesson Corp faces the constant threat of data breaches, necessitating robust security measures.
McKesson Segments
McKesson Revenue by Segment (1/5)
3 Years
5 Years
10 Years
Max
Details
McKesson Revenue by Segment (2/5)
3 Years
Max
Details
McKesson Revenue by Segment (3/5)
3 Years
Max
Details
McKesson Revenue by Segment (4/5)
Max
Details
McKesson Revenue by Segment (5/5)
3 Years
Max
Details
McKesson Revenue by Region
3 Years
5 Years
10 Years
Max
Details
McKesson Eulerpool Fair Value
McKesson historical P/E ratio, EBIT multiple, and P/S ratio
McKesson annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
McKesson shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
McKesson Dividend History
33 years of dividend payments · 3 consecutive increases
McKesson dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
McKesson dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
McKesson Earnings Calls
McKesson Earnings Estimates
McKesson Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/7/2026 | 11.66USD | 102.33 BUSD | 2026 Q4 |
| 2/4/2026 | 9.3USD | 106.92 BUSD | 2026 Q3 |
| 5/6/2024 | 6.81USD | 76.46 BUSD | 2024 Q4 |
| 1/30/2024 | 7.09USD | 78.4 BUSD | 2024 Q3 |
| 8/1/2023 | 6.15USD | 69.86 BUSD | 2024 Q1 |
| 5/3/2023 | 6.64USD | 68.55 BUSD | 2023 Q4 |
| 1/31/2023 | 6.44USD | 71.92 BUSD | 2023 Q3 |
| 11/1/2022 | 6.15USD | 71.19 BUSD | 2023 Q2 |
| 8/3/2022 | 5.33USD | 66.12 BUSD | 2023 Q1 |
| 5/5/2022 | 6.1USD | 64.56 BUSD | 2022 Q4 |
EESG©
Eulerpool ESG Scorecard© for the McKesson stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
McKesson shareholder structure
| % | Name |
|---|---|
9.80841% | |
5.50153% | |
4.65263% | |
3.14289% | |
2.8138% | |
2.30282% | |
1.85159% | |
1.85155% | |
1.5571% | |
1.50032% |
McKesson Executives and Management Board
Mr. Brian Tyler
(58)Chief Executive Officer, Director · since 2012
Mr. Britt Vitalone
(56)Chief Financial Officer, Executive Vice President
Ms. Michele Lau
(49)Executive Vice President, Chief Legal Officer
Ms. Leann Smith
(50)Chief Human Resources Officer, Executive Vice President
Mr. Thomas Rodgers
(49)Executive Vice President, Chief Strategy and Business Development Officer
McKesson Supply Chain
Frequently asked questions about McKesson
The business model of Mckesson Corp is centered around being a leading healthcare services and information technology company. Mckesson Corp provides various solutions to healthcare organizations including pharmaceuticals distribution, medical-surgical distribution, and healthcare technology. With a wide network and expertise in supply chain management, Mckesson Corp ensures the efficient distribution of pharmaceuticals and medical products to healthcare providers, helping them deliver quality patient care. Through its technology solutions and analytics, Mckesson Corp also supports healthcare organizations in managing their operations, improving clinical outcomes, and optimizing financial performance. This comprehensive approach enables Mckesson Corp to drive innovation and provide value across the healthcare industry.
McKesson stock
McKesson Peer Group
McKesson Ticker
McKesson FIGI
All fundamentals and in-depth analysis of McKesson
Our stock analysis for McKesson Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of McKesson Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.